REGENERON PHARMACEUTICALS, INC. - FORM 10-Q - EX-32 - CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 - October 28, 2010

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - REGENERON PHARMACEUTICALS, INC.Financial_Report.xls
10-Q - QUARTERLY REPORT - REGENERON PHARMACEUTICALS, INC.regeneron_10q.htm
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) - REGENERON PHARMACEUTICALS, INC.exhibit31-1.htm
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) - REGENERON PHARMACEUTICALS, INC.exhibit31-2.htm
EX-10.1 - AMENDMENT TO THE NON EXCLUSIVE LICENSE AND MATERIAL TRANSFER AGREEMENT - REGENERON PHARMACEUTICALS, INC.exhibit10-1.htm

Exhibit 32
 
Certification of CEO and CFO Pursuant to
18 U.S.C. Section 1350,
As Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
 
In connection with the Quarterly Report of Regeneron Pharmaceuticals, Inc. (the "Company") on Form 10-Q for the quarterly period ended September 30, 2010 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), Leonard S. Schleifer, M.D., Ph.D., as Chief Executive Officer of the Company, and Murray A. Goldberg, as Chief Financial Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, to the best of his knowledge, that:
 
     (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
     (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
   
/s/ LEONARD S. SCHLEIFER  
Leonard S. Schleifer, M.D., Ph.D.
Chief Executive Officer
October 28, 2010
 
 
/s/ MURRAY A. GOLDBERG  
Murray A. Goldberg
Chief Financial Officer
October 28, 2010

REGENERON PHARMACEUTICALS, INC. Reports